Bernadette R. Gochuico

National Institutes of Health — United States

Medicine · Health Sciences

44h-index7.2kcitations161works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(51), melanin and skin pigmentation(31), Cell Adhesion Molecules Research(13), Pulmonary Hypertension Research and Treatments(12), Medical Imaging and Pathology Studies(10)

Publications152 total

Epidemiology of childhood interstitial & diffuse lung diseases (chILD) via real-world data (RWD)
2025
Choline and CCL22 Are Prognostic Blood Biomarkers for Hermansky-Pudlak Syndrome Pulmonary Fibrosis
American Journal of Respiratory Cell and Molecular Biology·2025· 1 cited
Elevated blood anandamide levels in acute COVID-19 pneumonia with respiratory failure
The American Journal of the Medical Sciences·2025· 3 cited
A phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the porcupine inhibitor, AZD5055
iScience·2025· 2 citedOpen Access
Spatial Transcriptomics Reveals a Significant Overlap Between Early-stage Familial Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine·2025
Circulating Endocannabinoid Levels Increased in Acute Covid-19 Pneumonia With Respiratory Failure
American Journal of Respiratory and Critical Care Medicine·2025
Ectopic Expansion of Pulmonary Vasculature in Fibrotic Lung Disease and Lung Adenocarcinoma Marked by Proangiogenic COL15A1+ Endothelial Cells
Pulmonary Circulation·2025· 3 citedOpen Access
Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine·2025· 3 cited
Insights into the renal pathophysiology in Hermansky‐Pudlak syndrome‐1 from urinary extracellular vesicle proteomics and a new mouse model
FEBS Letters·2024· 2 citedOpen Access
Author response for "Insights into the renal pathophysiology in Hermansky‐Pudlak syndrome‐1 from urinary extracellular vesicle proteomics and a new mouse model"
2024
Type 2 innate immunity promotes the development of pulmonary fibrosis in Hermansky-Pudlak syndrome
JCI Insight·2024· 8 citedOpen Access
Impairment of Renal Function in Hermansky-Pudlak Syndrome
American Journal of Nephrology·2024· 4 citedOpen Access
Novel oral PORCN inhibitor does not alter the PK of nintedanib, an approved therapy for idiopathic pulmonary fibrosis
2024· 1 cited
Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis
2024· 2 citedOpen Access
Composite Fibrosis Scoring From Serum Biomarkers for Early Detection of Progressive Hermanky-Pudlak Syndrome Pulmonary Fibrosis
2024
A First-in-human Study in Healthy Volunteers Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5055, A Novel Oral Porcupine Inhibitor Under Development as a Treatment for Pulmonary Fibrosis
2024· 1 cited
Quantification of Proteus syndrome-associated lung disease
Orphanet Journal of Rare Diseases·2024· 2 citedOpen Access
SAT614 Clinical, Laboratory And Imaging Features Associated With Central Diabetes Insipidus (Arginine Vasopressin Deficiency) In Erdheim-Chester Disease (ECD)
Journal of the Endocrine Society·2023Open Access
Pulmonary function and structure abnormalities in children and young adults with osteogenesis imperfecta point to intrinsic and extrinsic lung abnormalities
Journal of Medical Genetics·2023· 8 citedOpen Access
Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy
Genetics in Medicine·2023· 7 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

William A. Gahl(19), Iván O. Rosas(18), Kevin O’Brien(9), Joel Moss(8), Juan C. Osorio(6), Naftali Kaminski(5), Souheil El‐Chemaly(5), Steven D. Nathan(5), Marjan Huizing(5), Jianhua Yao(4), Teri J. Franks(4), William D. Travis(4), Richard A. Hess(4), Thomas C. Markello(4), Sandra D. MacDonald(3), Jeffrey R. Galvin(3), Chester V. Oddis(3), Dana P. Ascherman(3), Melissa A. Merideth(3), Alan Fine(3)